SEARCH

SEARCH BY CITATION

References

  • 1
    Bousfield L, Pacey F, Young Q, Krumins I, Osborn R. Expanded cytologic criteria for the diagnosis of adenocarcinoma in situ of the cervix and related lesions. Acta Cytol 1980;24:28396.
  • 2
    Bose S, Kannan V, Kline TS. Abnormal endocervical cells. Really abnormal? Really endocervical? Am J Clin Pathol 1994;101:70813.
  • 3
    Kennedy AW, Salmieri SS, Wirth SL, Biscotti CV, Tuason LJ, Travarca MJ. Results of the clinical evaluation of atypical glandular cells of undetermined significance (AGCUS) detected on cervical cytology screening. Gynecol Oncol 1996;63:148.
  • 4
    Geier CS, Wilson M, Creasman W. Clinical evaluation of atypical glandular cells of undetermined significance. Am J Obstet Gynecol 2001;184:649.
  • 5
    Kim TJ, Kim HS, Park CT, Park IS, Hong SR, Park JS, Shim JU Clinical evaluation of follow-up methods and results of atypical glandular cells of undetermined significance (AGUS) detected on cervicovaginal Pap smears. Gynecol Oncol 1999;73:2928.
  • 6
    Chin AB, Bristow RE, Korst LM, Walts A, Lagasse LD. The significance of atypical glandular cells on routine cervical cytologic testing in a community-based population. Am J Obstet Gynecol 2000;182:127882.
  • 7
    Eltabbakh GH, Lipman JN, Mount SL, Morgan A. Significance of atypical glandular cells of undetermined significance on ThinPrep Papanicolaou smears. Gynecol Oncol 2000;78:24550.
  • 8
    DeSimone CP, Day ME, Tovar MM, Dietrich CS III, Eastham ML. Rate of pathology from atypical glandular cell Pap tests classified by the Bethesda 2001 nomenclature. Obstet Gynecol 2006;107:128591.
  • 9
    Tam KF, Cheung AN, Liu KL, Ng TY, Pun TC, Chan YM, Wong LC, Ng AW, Nagan HY. A retrospective review on atypical glandular cells of undetermined significance (AGUS) using the Bethesda 2001 classification. Gynecol Oncol 2003;91:6037.
  • 10
    Manetta A, Keefe K, Lin F, Ahdoot D, Kaleb V. Atypical glandular cells of undetermined significance in cervical cytologic findings. Am J Obstet Gynecol 1999;180:8838.
  • 11
    Krane JF, Lee KR, Sun D, Yuan L, Crum CP. Atypical glandular cells of undetermined significance. Outcome predictions based on human papillomavirus testing. Am J Clin Pathol 2004;121:8792.
  • 12
    Chhieng DC, Gallaspy S, Yang H, Roberson J, Eltoum I. Women with atypical glandular cells: a long-term follow-up study in a high-risk population. Am J Clin Pathol 2004;122:5759.
  • 13
    Kurman RJ, Henson DE, Herbst AL, Noller KL, Schiffman MH. Interim guidelines for management of abnormal cervical cytology. The 1992 National Cancer Institute Workshop. JAMA 1994;271:18669.
  • 14
    Brreslow N. Statistical Methods in Cancer Research. Vol. 2, The Design and Analysis of Cohort Studies. Geneva: World Health Organization; 1987. pp.6970.
  • 15
    Gatscha RM, Abadi M, Babore S, Chhieng D, Miller MJ, Saigo PE. Smears diagnosed as ASCUS: interobserver variation and follow-up. Diagn Cytopathol 2001;25:13840.
  • 16
    Solomon D, Schiffman M, Tarone R. Comparison of three management strategies for patients with atypical squamous cells of undetermined significance: baseline results from a randomized trial. J Natl Cancer Inst 2001;93:2939.
  • 17
    Sharpless KE, Schnatz PF, Mandavilli S, Greene JF, Sorosky JI. Dysplasia associated with atypical glandular cells on cervical cytology. Obstet Gynecol 2005;105:494500.
  • 18
    Coughlin SS, King J, Richards TB, Ekwueme DU. Cervical cancer screening among women in metropolitan areas of the United States by individual-level and area-based measures of socioeconomic status, 2000 to 2002. Cancer Epidemiol Biomarkers Prev 2006;15:21549.
  • 19
    Schnatz PF, Guile M, O’Sullivan DM, Sorosky JI. Clinical significance of atypical glandular cells on cervical cytology. Obstet Gynecol 2006; 107:7018.
  • 20
    Zhao C, Florea A, Onisko A, Austin RM. Histologic follow-up results in 662 patients with Pap test findings of atypical glandular cells: results from a large academic womens hospital laboratory employing sensitive screening methods. Gynecol Oncol 2009;114:3839.
  • 21
    Duska LR. Can we improve the detection of glandular cervical lesions: the role and limitations of the Pap smear diagnosis atypical glandular cells (AGC). Gynecol Oncol 2009;114:3812.
  • 22
    Thrall M, Kjeldahl K, Gulbahce HE, Pambuccian SE. Liquid-based Papanicolaou test (SurePath) interpretations before histologic diagnosis of endometrial hyperplasias and carcinomas: study of 272 cases classified by the 2001 Bethesda system. Cancer 2007;111: 21723.
  • 23
    Lai CR, Hsu CY, Tsay SH, Li AF. Clinical significance of atypical glandular cells by the 2001 Bethesda System in cytohistologic correlation. Acta Cytol 2008;52:5637.
  • 24
    Derchain SF, Rabelo-Santos SH, Sarian LO, Zeferino LC, De Oliveira Zambeli ER, Do Amaral Westin MC, De Angelo Andrade LA, Syrjänen KJ. Human papillomavirus DNA detection and histological findings in women referred for atypical glandular cells or adenocarcinoma in situ in their Pap smears. Gynecol Oncol 2004;95:61823.
  • 25
    Schnatz PF, Sharpless KE, O’Sullivan DM. Use of human papillomavirus testing in the management of atypical glandular cells. J Low Genit Tract Dis 2009;13:94101.
  • 26
    Wright TC Jr, Massad LS, Dunton CJ, Spitzer M, Wilkinson EJ, Solomon D. 2006 consensus guidelines for the management of women with abnormal cervical cancer screening tests. Am J Obstet Gynecol 2007;179:34655.